Odyssean LLC Invests $1.17 Million in Inspire Medical Systems, Inc. $INSP

Key Points

• Odyssean LLC purchased 26,282 shares of Inspire Medical Systems worth approximately $1.17 million, representing about 0.09% of the company. Institutional investors and hedge funds collectively own 94.91% of the stock.
• Analyst sentiment remains mixed, with the stock carrying an average “Hold” rating and a consensus price target of $66.19. Recent targets range from $39 to $59, while one firm issued a strong-buy rating.
• Inspire reported quarterly earnings of $0.14 per share, beating estimates by $0.38, and revenue of $200.58 million. However, revenue declined 7.6% year over year, and an insider recently sold 963 shares.

Odyssean LLC bought a new position in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 26,282 shares of the company's stock, valued at approximately $1,172,000. Odyssean LLC owned about 0.09% of Inspire Medical Systems as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. BlackRock Inc. acquired a new position in shares of Inspire Medical Systems in the 2nd quarter valued at $211,341,000. Wellington Management Group LLP acquired a new stake in Inspire Medical Systems during the 4th quarter worth about $203,929,000. Wasatch Advisors LP raised its holdings in Inspire Medical Systems by 7.2% during the 2nd quarter. Wasatch Advisors LP now owns 1,634,395 shares of the company's stock worth $212,095,000 after buying an additional 110,288 shares during the period. Morgan Stanley boosted its holdings in shares of Inspire Medical Systems by 179.5% in the fourth quarter. Morgan Stanley now owns 1,259,762 shares of the company's stock worth $116,188,000 after buying an additional 809,121 shares during the period. Finally, Deerfield Management Company L.P. increased its position in shares of Inspire Medical Systems by 648.4% in the third quarter. Deerfield Management Company L.P. now owns 1,047,694 shares of the company's stock worth $77,739,000 after acquiring an additional 907,694 shares in the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Jason Kelly sold 963 shares of Inspire Medical Systems stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $59.55, for a total transaction of $57,346.65. Following the sale, the insider directly owned 18,985 shares of the company's stock, valued at $1,130,556.75. This trade represents a 4.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.20% of the company's stock.

Analysts Set New Price Targets

INSP has been the topic of a number of recent analyst reports. Summit Redstone set a $39.00 price target on shares of Inspire Medical Systems in a report on Friday, May 22nd. Bank of America cut shares of Inspire Medical Systems from a "neutral" rating to an "underperform" rating and set a $39.00 price target for the company. in a report on Friday, May 22nd. Robert W. Baird boosted their price objective on shares of Inspire Medical Systems from $54.00 to $59.00 and gave the company a "neutral" rating in a research report on Tuesday, August 4th. Weiss Ratings upgraded Inspire Medical Systems from a "sell (d)" rating to a "sell (d+)" rating in a research note on Wednesday, August 19th. Finally, Freedom Capital raised Inspire Medical Systems to a "strong-buy" rating in a research report on Tuesday, June 30th. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $66.19.

Inspire Medical Systems Stock Performance

Inspire Medical Systems stock opened at $62.99 on Friday. Inspire Medical Systems, Inc. has a 52 week low of $38.91 and a 52 week high of $147.03. The firm has a market capitalization of $1.82 billion, a PE ratio of 13.63, a PEG ratio of 4.72 and a beta of 0.70. The business's 50-day simple moving average is $55.05 and its 200-day simple moving average is $52.43.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.38. The firm had revenue of $200.58 million during the quarter, compared to the consensus estimate of $194.72 million. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The firm's revenue for the quarter was down 7.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.45 EPS. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Research analysts forecast that Inspire Medical Systems, Inc. will post 1.24 earnings per share for the current year.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company's flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source